Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(75%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Terminated3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%
terminated375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery

NCT05064189
terminatednot_applicable

Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease

NCT05053789
terminatednot_applicable

Effect of Chitosan-N-acetylcysteine on Subjective Pain Sensation in Corneal Abrasion

NCT05049642
terminatednot_applicable

Effect of Chitosan-N-Acetylcysteine on IOL-power Prior to Cataract Surgery

NCT05049629

Clinical Trials (4)

Showing 4 of 4 trials
NCT05064189Not Applicable

Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery

Completed
NCT05053789Not Applicable

Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease

Terminated
NCT05049642Not Applicable

Effect of Chitosan-N-acetylcysteine on Subjective Pain Sensation in Corneal Abrasion

Terminated
NCT05049629Not Applicable

Effect of Chitosan-N-Acetylcysteine on IOL-power Prior to Cataract Surgery

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4